An Effect of the PAI-1 4G/5G Polymorphism on Cholesterol Levels May Explain Conflicting Associations with Myocardial Infarction and Stroke
Authors:
- Giorgio B. BoncoraglioGBGiorgio B. Boncoraglio
- Antonella BodiniABAntonella Bodini
- Carla BrambillaCBCarla Brambilla
- Maria Rita CarrieroMCMaria Rita Carriero
- Emilio CiusaniECEmilio Ciusani
- Eugenio A. ParatiEPEugenio A. Parati
- 1 July 2006
- journal article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 22 (2-3) , 191-195
Abstract
Background and Purpose:The gene-encoding plasminogen activator inhibitor type 1 (PAI-1) has a common 4G/5G ‘functional’ polymorphism, and people homozygous for the 4G allele have higher PAI-1 plasma concentrations. The 4G/4G genotype is associated with increased risk of myocardial infarction but paradoxically protects against stroke. We hypothesized that this paradox may be explained via an effect of the PAI-1 polymorphism on plasma lipids. Methods: We studied 71 consecutive Italian patients referred to our Institute for first stroke or vascular cognitive impairment. PAI-1 gene 4G/5G polymorphism, total plasma cholesterol, plasma triglycerides, sex, age, smoking, oral contraceptive use, statin therapy, hypertension, diabetes, and history of myocardial infarction were examined. Results:The 4G/4G genotype was significantly associated with high cholesterol (p = 0.003) but not with triglycerides (p = 0.39). Adjusted odds ratios were: 5.8 for 4G/4G vs. 4G/5G (95% CI, 3.1–23.0), and 15.9 for 4G/4G vs. 5G/5G (95% CI, 2.4–105.0). Conclusions:This finding may explain the involvement of the PAI-1 polymorphism in the clustering of atherothrombotic risk factors, and why people with the 4G/4G genotype are at increased risk for myocardial infarction. Stroke is not so clearly related to hypercholesterolemia and other effects of the 4G/4G genotype (perhaps increased PAI-1 expression) may protect against stroke.Keywords
This publication has 19 references indexed in Scilit:
- A haplotype map of the human genomeNature, 2005
- Fibrinolytic Gene Polymorphism and Ischemic StrokeStroke, 2005
- Plasminogen Activators Contribute to Impairment of Hypercapnic and Hypotensive Cerebrovasodilation After Cerebral Hypoxia/Ischemia in the Newborn PigStroke, 2005
- Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of StrokeStroke, 2005
- What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?BMJ, 2005
- Stroke and CholesterolStroke, 2004
- Editorial Comment— Genetic Make-Up for Increased PAI-1 Expression Protects Against StrokeStroke, 2003
- The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1Blood, 2003
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993